NCCID hosts the Public Health Agency of Canada Webinars on COVID-19 Vaccines for Health Care Providers

The Public Health Agency of Canada provides webinars for Health Care Providers (HCPs) on COVID-19 vaccines. Webinars are available, and continue to be developed, on different topics that target experienced vaccine providers, new and returning vaccine providers and public health decision makers. The webinars are live, include a moderated Q&A and are available in English and French. Recorded webinar events and presentations are available as follows:

Webinars on the foundations of vaccine systems in Canada: These webinars inform HCPs on vaccine authorization and regulation, guidance and administration.

Webinars on authorized COVID-19 vaccines in Canada: These webinars present the National Advisory Committee on Immunization (NACI) guidance and recommendations on the use of the COVID-19 vaccines authorized in Canada, and offer an opportunity for HCPs to have their questions answered.

Webinars on emerging topics: New topics of interest for COVID-19 vaccines are discussed in these webinars and offer an opportunity for HCPs to have their questions answered.


Webinars on the foundations of vaccine systems in Canada

PHAC: COVID-19 Variants and Vaccines
PHAC: Addressing COVID-19 Vaccine Hesitancy in Clinical Practice
PHAC: COVID-19 Vaccines Planning for Immunization Clinics
PHAC: COVID-19 Vaccines Foundational Webinar

Webinars on authorized COVID-19 vaccines in Canada

Recommendations of the National Advisory Committee on Immunization (NACI) on Extended Dose Intervals for COVID-19 Vaccines
Recommendations of the National Advisory Committee on Immunization (NACI) on the use of the Moderna COVID-19 vaccine
Recommendations of the National Advisory Committee on Immunization (NACI) on the use of the Pfizer-BioNTech COVID-19 vaccine

Webinars on emerging topics

PHAC: COVID-19 Vaccine Emerging Issues Webinar: Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT)

PHAC: COVID-19 Vaccines Emerging Issues: Delayed Injection Site Reactions
PHAC: COVID-19 Vaccines Emerging Issues: Allergies and LDV Syringe Discussion